The Council on Radionuclides and Radiopharmaceuticals Inc. (CORAR) — the voice of the radionuclide, radiopharmaceutical and nuclear pharmacy industries in North America — strongly supports legislation recently introduced by Congressman George Holding (R-NC-2) and Seth Moulton (D-MA-6). This legislation, designated H.R. 6948 - Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2018, would direct the Secretary of Health and Human Services to recognize diagnostic radiopharmaceuticals (RPs) as drugs and institute a separate payment policy under the Medicare Hospital Outpatient Prospective Payment System (OPPS).
October 12, 2018
Videos
Professor Ian Meredith, MBBS, Ph.D., global chief medical officer and executive vice president, Boston Scientific ...
October 11, 2018
Videos
A discussion with Professor Ian Meredith, MBBS, Ph.D., global chief medical officer and executive vice president, Boston ...
October 11, 2018Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
News | Pharmaceuticals
Novel results from the landmark EMPA-REG OUTCOME trial suggest that treatment with Jardiance positively impacts life expectancy in adults with type 2 diabetes and established cardiovascular disease. Using actuarial methods, and assuming that the demonstrated beneficial effects of Jardiance remain consistent with long-term use, Jardiance was estimated to extend life expectancy by 1 to 4.5 years on average, depending on age, when compared with placebo. This analysis suggests that treatment with Jardiance could add years of life. The results were published in the journal Circulation.
October 11, 2018
News | Ultrasound Imaging
Canon Medical Systems USA Inc. launched an all-new program designed to help reduce the leading causes of pain and injury for sonographers from work-related musculoskeletal disorders, which afflict up to 90 percent of clinical sonographers. The Healthy Sonographer Program aims to educate sonographers about best practices to prevent positioning themselves in awkward postures – including reaching and twisting – which can result in injuries to the shoulders, neck and wrists and can be a detriment to patient engagement.
October 10, 2018
Technology | Cardiovascular Business
October 10, 2018 — Medical coding software provider ZHealth recently unveiled Etch, the first-ever software platform ...
October 10, 2018Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Feature | Cardiovascular Business | John Larson
Years ago, I owned a computer that ran a spreadsheet program called Lotus 1-2-3. After about a year, I needed to perform ...
October 10, 2018
Technology
Biosense Webster Inc. recently received approval from the U.S. Food and Drug Administration (FDA) for its Visitag Surpoint External Processing Unit, and enrollment has begun in its post-market approval study.
October 09, 2018
Technology | Magnetic Resonance Imaging (MRI)
The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Sola, a 1.5 Tesla magnetic resonance imaging (MRI) scanner from Siemens Healthineers that brings Siemens’ BioMatrix technology to the 1.5T market. This technology addresses patient anatomical and physiological differences, as well as differences in how users set up and conduct MRI exams, to increase productivity and decrease rescans for improved efficiency and patient satisfaction.
October 09, 2018Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News | Cardiac Diagnostics
Tracking just seven factors of heart attack patients when they are first admitted to the hospital can help flag those most at risk for 30-day readmission, researchers from UT Southwestern found.
October 09, 2018
Technology | Mobile Devices
The U.S. Food and Drug Administration (FDA) granted market clearance for FibriCheck, a Belgian medical smartphone application for the detection of heart rhythm disorders. The approval makes FibriCheck the first-FDA approved app for heart rhythm disorders by using only an optical signal originating from a non-medical device such as a smartphone.
October 08, 2018
News | Endovascular Aortic Repair
Endologix Inc. received notice that the U.S. Food and Drug Administration (FDA) has classified a voluntary recall action that Endologix took in July of this year as a Class I recall. The July recall involved Endologix’s issuance of a Safety Notice to healthcare professionals (HCPs) using the AFX Endovascular AAA System.
October 08, 2018Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Feature | Cardiovascular Information Systems (CVIS) | Val Kapitula RT(R), PMP, CIIP
“I don’t trust anything that’s being portrayed in the marketing brochures and will believe it only when the solution is ...
October 05, 2018
Technology | Stents Peripheral
Veryan Medical Ltd has received Premarket Approval (PMA) for the BioMimics 3D Vascular Stent System from the U.S. Food & Drug Administration (FDA). The device is approved for the treatment of symptomatic de novo or restenotic lesions in the native superficial femoral artery and/or proximal popliteal artery.
October 05, 2018
News | Vascular Closure Devices
Teleflex Inc. announced the acquisition of Essential Medical Inc. Based in Exton, Pa., Essential Medical is a privately-held medical device company that has developed and commercialized the CE Marked Manta Vascular Closure Device specifically designed for closure of large bore arteriotomies following procedures utilizing devices or sheaths ranging in size from 10F to 18F (with maximum outer diameters up to 25F).
October 05, 2018© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now